How much is the market price of a box of new trametinib in 2024?

Trametinib (Trametinib belongs to a group of drugs called antineoplastic drugs (cancer drugs). They are used alone or in combination with dabrafenib to treat melanoma (skin cancer) that has spread or cannot be removed by surgery. They can also help prevent melanoma from coming back after surgery. This approach is used to treat melanoma cells only if they have the BRAF V600E or V600K mutation.

Tramatinib is also used together withdabrafenib to treat non-small cell lung cancer that has spread and anaplastic thyroid cancer that has spread and has no satisfactory treatment options. It is also used only when the non-small cell lung cancer cells and ATC cells have the BRAF V600E mutation. Tramatinib is also used in combination with dabrafenib to treat solid tumors that have spread, cannot be removed by surgery, or have worsened (progressed) for which there are no satisfactory treatment options, and only when the solid tumor has a BRAF V600E mutation. Tramatinib in combination with dabrafenib can also be used to treat low-grade gliomas that require other treatments, and is only used when the brain tumor has the BRAF V600E mutation.

The original drug of Trametinib has been launched in China and is included in the scope of medical insurance, but it may only be available to patients who meet the indications. The price of 2 mg*30 tablets is more than RMB 10,000. The original drug of Trametinib sold overseas, with the price of 2 mg*30 tablets, is more than RMB 7,000 (the price may fluctuate due to exchange rates). There are also generic trametinib drugs produced in other countries overseas, and their drug ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of a 2mg*30 tablet of a generic drug produced by a Laos pharmaceutical factory is more than 2,000 yuan (the price may fluctuate due to the exchange rate).